Associate Professor Rani Khatib

Associate Professor Rani Khatib

Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds (United Kingdom of Great Britain & Northern Ireland)

Member of:

A Consultant Pharmacist in Cardiology and Cardiovascular Research leading on multiple local and national Cardiometabolic Risk and Medicines Optimisation projects. Based at Leeds Teaching Hospitals NHS Trust, UK. Visiting Associate Professor at the University of Leeds. National Clinical Champion for PCSK9i & Lipids Optimisation at NHS England and one of the clinical leads for the Accelerated Access Collaborative on PCSK9i. ESC ACNAP science Committee member, NICE Heart Failure Guidelines Committee member, Chair of UKCPA Cardiac Group. Areas of interest include: Post Myocardial Infarction Care, Medicines Adherence, Person-centred Care, Prevention, Ischaemic Heart Disease, Lipid Management, PCSK9i & Statin intolerance, Cardiometabolic Clinics, Heart Failure, Atrial Fibrillation, Anticoagulation, and Hypertension.

Presentations Events Articles Podcasts

#SoMe Marathon - have you got what it takes?

Event: ESC Congress 2023

Topic: Other

Session: #SoMe Marathon - have you got what it takes?

Access

Shared learning experience: innovative service models in cardiometabolic care to facilitate optimisation of pharmacological treatment and improve patient outcomes

Event: ESC Congress 2023

Topic: Treatment

Session: Shared learning experience: innovative service models in cardiometabolic care to facilitate optimisation of pharmacological treatment and improve patient outcomes

Access

Shared learning experience: innovative service models in cardiometabolic care to facilitate optimisation of pharmacological treatment and improve patient outcomes

Event: ESC Congress 2023

Topic: Treatment

Session: Shared learning experience: innovative service models in cardiometabolic care to facilitate optimisation of pharmacological treatment and improve patient outcomes

Access

Medicines, risk optimisation findings, and exploration of patient needs

Event: ACNAP Congress 2023

Topic: Acute Coronary Syndromes

Session: Real-world experience from an MDT cardiometabolic clinic

Access

Questions, panel discussion and close

Event: ACNAP Congress 2023

Topic: Allied Professions in Cardiovascular Care

Session: What roles do we play in transforming the NHS? Industry partnerships and allied professionals driving innovative models of care

Access

Improving patient health outcomes and optimisation of care through the development of a cardiometabolic medicines optimisation clinic

Event: ACNAP Congress 2023

Topic: Allied Professions in Cardiovascular Care

Session: What roles do we play in transforming the NHS? Industry partnerships and allied professionals driving innovative models of care

Access

Recognising and treating hypertension: guidelines vs. reality.

Event: ACNAP-EuroHeartCare 2022

Topic: Risk Factors and Prevention

Session: Reducing adverse outcomes in cardiovascular disease: making each interaction count

Access

Innovative 12 months ticagrelor virtual clinic - supporting appropriate extended dual anti-platelet therapy in post MI

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic) ePosters

Access

The development of the My Experience of Taking Medicines Questionnaire (MYMEDS) for patients with coronary heart disease

Event: ESC Congress 2018

Topic: Secondary Prevention

Session: Secondary prevention

Access

Prevalence of iron studies during admission of heart failure patients to leeds teaching hospitals

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Access

Associate Professor Rani Khatib

Biography

Contributor content

#SoMe Marathon - have you got what it takes?

Shared learning experience: innovative service models in cardiometabolic care to facilitate optimisation of pharmacological treatment and improve patient outcomes

Shared learning experience: innovative service models in cardiometabolic care to facilitate optimisation of pharmacological treatment and improve patient outcomes

Medicines, risk optimisation findings, and exploration of patient needs

Questions, panel discussion and close

Improving patient health outcomes and optimisation of care through the development of a cardiometabolic medicines optimisation clinic

Recognising and treating hypertension: guidelines vs. reality.

Innovative 12 months ticagrelor virtual clinic - supporting appropriate extended dual anti-platelet therapy in post MI

The development of the My Experience of Taking Medicines Questionnaire (MYMEDS) for patients with coronary heart disease

Prevalence of iron studies during admission of heart failure patients to leeds teaching hospitals

ESC 365 is supported by